Get started
Author

Cayla J. Saret

The Changing Face of the Cost-Utility Literature, 1990–2012
2015 · Peter J. Neumann, Teja Thorat, et al. · Value in Health · 103
PDF
A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
2016 · Peter J. Neumann, Teja Thorat, et al. · PLoS ONE · 92
PDF
Social Interactions and Social Activities After Burn Injury: A Life Impact Burn Recovery Evaluation (LIBRE) Study
2018 · Emily A Ohrtman, Gabriel D Shapiro, et al. · Journal of Burn Care & Research · 46
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses
2015 · Cayla J. Saret, Aaron N. Winn, et al. · Blood · 39
Examining Evidence in U.s. Payer Coverage Policies for Multi-gene Panels and Sequencing Tests
2017 · James D. Chambers, Cayla J. Saret, et al. · International Journal of Technology Assessment in Health Care · 24
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncology
2015 · Natalia Olchanski, Yue Zhong, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 23
Burn survivors injured as children exhibit resilience in long-term community integration outcomes: A life impact burn recovery evaluation (LIBRE) study
2019 · Sara Cartwright, Cayla Saret, et al. · Burns · 18
Interpreting Life Impact Burn Recovery Evaluation Profile Scores for Use by Clinicians, Burn Survivors, and Researchers
2020 · Mary D Slavin, Colleen M Ryan, et al. · Journal of Burn Care & Research · 13
Social Participation of Burn Survivors and the General Population in Work and Employment: A Life Impact Burn Recovery Evaluation (LIBRE) Profile Study
2019 · Cayla J Saret, Pengsheng Ni, et al. · Journal of Burn Care & Research · 9
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study
2016 · Pei-Jung Lin, Cayla J. Saret, et al. · PharmacoEconomics · 8
When Does FDAMA Section 114 Apply? Ten Case Studies
2015 · Peter J. Neumann, Cayla J. Saret · Value in Health · 3
PDF
Is the US “leading from behind” on health policy?
2013 · Peter J. Neumann, Cayla J. Saret · The European Journal of Health Economics · 3
PDF
A survey of individuals in US-based pharmaceutical industry HEOR departments: attitudes on policy topics
2013 · Peter J Neumann, Cayla J Saret · Expert Review of Pharmacoeconomics & Outcomes Research · 3
61 Measuring Social Integration using the LIBRE Profile: Reliability and Validity Assessments
2018 · E Dore, M Marino, et al. · Journal of Burn Care & Research · 2
275 Social Interactions and Social Activities after Burn Injury: A Life Impact Burn Recovery Evaluation (LIBRE) Study
2018 · E A Ohrtman, L C Simko, et al. · Journal of Burn Care & Research · 2
Geographic Variation In Local Medicare Coverage For Part B Biologics
2013 · CJ Saret, MJ Cangelosi, et al. · Value in Health · 1
Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis
2016 · P Lin, CJ Saret, et al. · Value in Health
PDF
Price and value in cancer care
2015 · Cayla J. Saret, Joshua T. Cohen, et al. · Cancer
PDF
When can pharmaceutical companies communicate health economic claims to payers? 10 case studies
2015 · P.J. Neumann, C.J. Saret · Value in Health
Potential savings in Healthcare spending on “low-value” interventions: case study of Arthroscopic Knee Surgery
2015 · P.B. Rane, N. Olchanski, et al. · Value in Health
The changing Face of the Cost-Utility Literature, 1990–2012
2015 · T. Thorat, J. Shi, et al. · Value in Health
PDF
Value of Innovation in Leukemia, Lymphoma, and Myeloma: A Systematic Review
2014 · C.J. Saret, A. Winn, et al. · Value in Health
Population Health Model: Projecting Health Trajectory Of The Massachusetts Population
2014 · N. Olchanski, Y. Zhong, et al. · Value in Health
PDF
Economics of costs in added years of life: A review of methodologic practices and consequences for cost-effectiveness
2013 · N. Olchanski, Y. Zhong, et al. · Value in Health
Works count: 24
Citation count: 389
H-index: 9
I10-index: 8
Year
Topic
Type